{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:43:16Z","timestamp":1793911396791,"version":"4.8.0"},"reference-count":273,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12022-022-09705-5","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T17:02:11Z","timestamp":1647190931000},"page":"197-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes"],"prefix":"10.1007","volume":"33","author":[{"given":"Vania","family":"Nos\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel Cameselle","family":"Teijeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurel","family":"Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,13]]},"reference":[{"key":"9705_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.annpat.2020.01.002","volume":"40","author":"A Couvelard","year":"2020","unstructured":"Couvelard A and Scoazec JY (2020) [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms]. Ann Pathol 40:120-133 https:\/\/doi.org\/10.1016\/j.annpat.2020.01.002","journal-title":"Ann Pathol"},{"key":"9705_CR2","doi-asserted-by":"publisher","first-page":"T195","DOI":"10.1530\/ERC-17-0243","volume":"24","author":"R Alrezk","year":"2017","unstructured":"Alrezk R, Hannah-Shmouni F and Stratakis CA (2017) MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr Relat Cancer 24:T195-T208 https:\/\/doi.org\/10.1530\/ERC-17-0243","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR3","doi-asserted-by":"publisher","unstructured":"Slingerland J and Pagano M (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183:10-7\u00a0https:\/\/doi.org\/10.1002\/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I"},{"key":"9705_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ng.2821","volume":"45","author":"JM Francis","year":"2013","unstructured":"Francis JM, Kiezun A, Ramos AH et al (2013) Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet 45:1483-6 https:\/\/doi.org\/10.1038\/ng.2821","journal-title":"Nat Genet"},{"key":"9705_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.beem.2010.01.001","volume":"24","author":"M Georgitsi","year":"2010","unstructured":"Georgitsi M (2010) MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Best Pract Res Clin Endocrinol Metab 24:425-37 https:\/\/doi.org\/10.1016\/j.beem.2010.01.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9705_CR6","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1210\/jc.2017-02324","volume":"103","author":"D Taieb","year":"2018","unstructured":"Taieb D, Jha A, Guerin C et al (2018) 18F-FDOPA PET\/CT Imaging of MAX-Related Pheochromocytoma. J Clin Endocrinol Metab 103:1574-1582 https:\/\/doi.org\/10.1210\/jc.2017-02324","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR7","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon N, Cascon A, Schiavi F et al (2012) MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res 18:2828-37 https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0160","journal-title":"Clin Cancer Res"},{"key":"9705_CR8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","volume":"3","author":"B Bausch","year":"2017","unstructured":"Bausch B, Schiavi F, Ni Y et al (2017) Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention. JAMA Oncol 3:1204-1212 https:\/\/doi.org\/10.1001\/jamaoncol.2017.0223","journal-title":"JAMA Oncol"},{"key":"9705_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/CAD.0000000000000570","volume":"29","author":"AM Ferrara","year":"2018","unstructured":"Ferrara AM, Lombardi G, Pambuku A et al (2018) Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma. Anticancer Drugs 29:102-105 https:\/\/doi.org\/10.1097\/CAD.0000000000000570","journal-title":"Anticancer Drugs"},{"key":"9705_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s40792-017-0408-x","volume":"3","author":"M Shibata","year":"2017","unstructured":"Shibata M, Inaishi T, Miyajima N et al (2017) Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report. Surg Case Rep 3:131 https:\/\/doi.org\/10.1186\/s40792-017-0408-x","journal-title":"Surg Case Rep"},{"key":"9705_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2015-2592","volume":"101","author":"E Korpershoek","year":"2016","unstructured":"Korpershoek E, Koffy D, Eussen BH et al (2016) Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis. J Clin Endocrinol Metab 101:453-60 https:\/\/doi.org\/10.1210\/jc.2015-2592","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fendo.2020.00234","volume":"11","author":"C Pozza","year":"2020","unstructured":"Pozza C, Sesti F, Di Dato C et al (2020) A Novel MAX Gene Mutation Variant in a Patient With Multiple and \"Composite\" Neuroendocrine-Neuroblastic Tumors. Front Endocrinol (Lausanne) 11:234 https:\/\/doi.org\/10.3389\/fendo.2020.00234","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9705_CR13","doi-asserted-by":"publisher","first-page":"L37","DOI":"10.1530\/ERC-18-0065","volume":"25","author":"AF Daly","year":"2018","unstructured":"Daly AF, Castermans E, Oudijk L et al (2018) Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocr Relat Cancer 25:L37-L42 https:\/\/doi.org\/10.1530\/ERC-18-0065","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR14","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1210\/js.2017-00135","volume":"1","author":"KL Roszko","year":"2017","unstructured":"Roszko KL, Blouch E, Blake M et al (2017) Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas. J Endocr Soc 1:1401-1407 https:\/\/doi.org\/10.1210\/js.2017-00135","journal-title":"J Endocr Soc"},{"key":"9705_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","volume":"106","author":"AJ Seabrook","year":"2021","unstructured":"Seabrook AJ, Harris JE, Velosa SB et al (2021) Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5? J Clin Endocrinol Metab 106:1163-1182 https:\/\/doi.org\/10.1210\/clinem\/dgaa957","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR16","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1200\/JCO.2010.32.2156","volume":"29","author":"RH Grogan","year":"2011","unstructured":"Grogan RH, Pacak K, Pasche L, Huynh TT and Greco RS (2011) Bilateral adrenal medullary hyperplasia associated with an SDHB mutation. J Clin Oncol 29:e200-2 https:\/\/doi.org\/10.1200\/JCO.2010.32.2156","journal-title":"J Clin Oncol"},{"key":"9705_CR17","first-page":"1154","volume":"49","author":"M Yagita","year":"1989","unstructured":"Yagita M, Itoh K, Tsudo M et al (1989) Involvement of both Tac and non-Tac interleukin 2-binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes. Cancer Res 49:1154-9","journal-title":"Cancer Res"},{"key":"9705_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/PAS.0b013e3181874eca","volume":"33","author":"M Anlauf","year":"2009","unstructured":"Anlauf M, Bauersfeld J, Raffel A et al (2009) Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. Am J Surg Pathol 33:339-46 https:\/\/doi.org\/10.1097\/PAS.0b013e3181874eca","journal-title":"Am J Surg Pathol"},{"key":"9705_CR19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1073\/pnas.1712262115","volume":"115","author":"D Iacovazzo","year":"2018","unstructured":"Iacovazzo D, Flanagan SE, Walker E et al (2018) MAFA missense mutation causes familial insulinomatosis and diabetes mellitus. Proc Natl Acad Sci U S A 115:1027-1032 https:\/\/doi.org\/10.1073\/pnas.1712262115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9705_CR20","doi-asserted-by":"publisher","unstructured":"Snaith JR, McLeod D, Richardson A, Chipps D (2020) Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomy. Endocrinol Diabetes Metab Case Rep 2020\u00a0https:\/\/doi.org\/10.1530\/EDM-20-0091","DOI":"10.1530\/EDM-20-0091"},{"key":"9705_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00905-8","author":"IA Gonzalez","year":"2021","unstructured":"Gonzalez IA, Stewart DR, Schultz KAP, Field AP, Hill DA and Dehner LP (2021) DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma. Mod Pathol https:\/\/doi.org\/10.1038\/s41379-021-00905-8","journal-title":"Mod Pathol"},{"key":"9705_CR22","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/humu.23877","volume":"40","author":"L de Kock","year":"2019","unstructured":"de Kock L, Wu MK and Foulkes WD (2019) Ten years of DICER1 mutations: Provenance, distribution, and associated phenotypes. Hum Mutat 40:1939-1953 https:\/\/doi.org\/10.1002\/humu.23877","journal-title":"Hum Mutat"},{"key":"9705_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/cncy.22327","volume":"128","author":"V Nose","year":"2020","unstructured":"Nose V (2020) DICER1 gene alterations in thyroid diseases. Cancer Cytopathol 128:688-689 https:\/\/doi.org\/10.1002\/cncy.22327","journal-title":"Cancer Cytopathol"},{"key":"9705_CR24","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1210\/jc.2017-02698","volume":"103","author":"JD Wasserman","year":"2018","unstructured":"Wasserman JD, Sabbaghian N, Fahiminiya S et al (2018) DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 103:2009-2015 https:\/\/doi.org\/10.1210\/jc.2017-02698","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ajcp\/aqy004","volume":"149","author":"I Gullo","year":"2018","unstructured":"Gullo I, Batista R, Rodrigues-Pereira P et al (2018) Multinodular Goiter Progression Toward Malignancy in a Case of DICER1 Syndrome: Histologic and Molecular Alterations. Am J Clin Pathol 149:379-386 https:\/\/doi.org\/10.1093\/ajcp\/aqy004","journal-title":"Am J Clin Pathol"},{"key":"9705_CR26","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1089\/thy.2019.0233","volume":"30","author":"YA Lee","year":"2020","unstructured":"Lee YA, Im SW, Jung KC et al (2020) Predominant DICER1 Pathogenic Variants in Pediatric Follicular Thyroid Carcinomas. Thyroid 30:1120-1131 https:\/\/doi.org\/10.1089\/thy.2019.0233","journal-title":"Thyroid"},{"key":"9705_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41379-020-0458-7","volume":"33","author":"RD Chernock","year":"2020","unstructured":"Chernock RD, Rivera B, Borrelli N et al (2020) Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Mod Pathol 33:1264-1274 https:\/\/doi.org\/10.1038\/s41379-020-0458-7","journal-title":"Mod Pathol"},{"key":"9705_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/thy.2018.0607","volume":"30","author":"M Bongiovanni","year":"2020","unstructured":"Bongiovanni M, Sykiotis GP, La Rosa S et al (2020) Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma. Thyroid 30:72-80 https:\/\/doi.org\/10.1089\/thy.2018.0607","journal-title":"Thyroid"},{"key":"9705_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s12105-020-01208-1","volume":"15","author":"LS Hellgren","year":"2021","unstructured":"Hellgren LS, Hysek M, Jatta K, Zedenius J and Juhlin CC (2021) Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature. Head Neck Pathol 15:668-675 https:\/\/doi.org\/10.1007\/s12105-020-01208-1","journal-title":"Head Neck Pathol"},{"key":"9705_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11102-011-0328-x","volume":"15","author":"BW Scheithauer","year":"2012","unstructured":"Scheithauer BW, Horvath E, Abel TW et al (2012) Pituitary blastoma: a unique embryonal tumor. Pituitary 15:365-73 https:\/\/doi.org\/10.1007\/s11102-011-0328-x","journal-title":"Pituitary"},{"key":"9705_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Plourde F et al (2014) Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol 128:111-22 https:\/\/doi.org\/10.1007\/s00401-014-1285-z","journal-title":"Acta Neuropathol"},{"key":"9705_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00401-008-0388-9","volume":"116","author":"BW Scheithauer","year":"2008","unstructured":"Scheithauer BW, Kovacs K, Horvath E et al (2008) Pituitary blastoma. Acta Neuropathol 116:657-66 https:\/\/doi.org\/10.1007\/s00401-008-0388-9","journal-title":"Acta Neuropathol"},{"key":"9705_CR33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/PAS.0000000000001430","volume":"44","author":"LM Rooper","year":"2020","unstructured":"Rooper LM, Bynum JP, Miller KP et al (2020) Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas: Molecular Characterization and Proposal for a Separate Classification. Am J Surg Pathol 44:826-833 https:\/\/doi.org\/10.1097\/PAS.0000000000001430","journal-title":"Am J Surg Pathol"},{"key":"9705_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jasc.2020.04.008","volume":"9","author":"DL Miller","year":"2020","unstructured":"Miller DL, Thompson LDR, Bishop JA, Rooper LM and Ali SZ (2020) Malignant teratomas of the thyroid gland: clinico-radiologic and cytomorphologic features of a rare entity. J Am Soc Cytopathol 9:221-231 https:\/\/doi.org\/10.1016\/j.jasc.2020.04.008","journal-title":"J Am Soc Cytopathol"},{"key":"9705_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00428-020-02853-1","volume":"477","author":"A Agaimy","year":"2020","unstructured":"Agaimy A, Witkowski L, Stoehr R et al (2020) Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term \"thyroblastoma\" more appropriate? Virchows Arch 477:787-798 https:\/\/doi.org\/10.1007\/s00428-020-02853-1","journal-title":"Virchows Arch"},{"key":"9705_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13044-018-0055-8","volume":"11","author":"J Yang","year":"2018","unstructured":"Yang J, Sarita-Reyes C, Kindelberger D and Zhao Q (2018) A rare malignant thyroid carcinosarcoma with aggressive behavior and DICER1 gene mutation: a case report with literature review. Thyroid Res 11:11 https:\/\/doi.org\/10.1186\/s13044-018-0055-8","journal-title":"Thyroid Res"},{"issue":"Suppl 2","key":"9705_CR37","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1038\/modpathol.2010.147","volume":"24","author":"V Nose","year":"2011","unstructured":"Nose V (2011) Familial thyroid cancer: a review. Mod Pathol 24 Suppl 2:S19-33 https:\/\/doi.org\/10.1038\/modpathol.2010.147","journal-title":"Mod Pathol"},{"key":"9705_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12022-010-9135-6","volume":"21","author":"V Nose","year":"2010","unstructured":"Nose V (2010) Familial follicular cell tumors: classification and morphological characteristics. Endocr Pathol 21:219-26 https:\/\/doi.org\/10.1007\/s12022-010-9135-6","journal-title":"Endocr Pathol"},{"key":"9705_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/his.13373","volume":"72","author":"J Guilmette","year":"2018","unstructured":"Guilmette J and Nose V (2018) Hereditary and familial thyroid tumours. Histopathology 72:70-81 https:\/\/doi.org\/10.1111\/his.13373","journal-title":"Histopathology"},{"key":"9705_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/PAP.0b013e31818a64af","volume":"15","author":"J Dotto","year":"2008","unstructured":"Dotto J and Nose V (2008) Familial thyroid carcinoma: a diagnostic algorithm. Adv Anat Pathol 15:332-49 https:\/\/doi.org\/10.1097\/PAP.0b013e31818a64af","journal-title":"Adv Anat Pathol"},{"key":"9705_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/PAP.0b013e3181f8b028","volume":"17","author":"V Nose","year":"2010","unstructured":"Nose V (2010) Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol 17:428-36 https:\/\/doi.org\/10.1097\/PAP.0b013e3181f8b028","journal-title":"Adv Anat Pathol"},{"key":"9705_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12022-020-09661-y","volume":"32","author":"JM Cameselle-Teijeiro","year":"2021","unstructured":"Cameselle-Teijeiro JM, Mete O, Asa SL and LiVolsi V (2021) Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates. Endocr Pathol 32:77-101 https:\/\/doi.org\/10.1007\/s12022-020-09661-y","journal-title":"Endocr Pathol"},{"key":"9705_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/thy.2010.0226","volume":"21","author":"AR Laury","year":"2011","unstructured":"Laury AR, Bongiovanni M, Tille JC, Kozakewich H and Nose V (2011) Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. Thyroid 21:135-44 https:\/\/doi.org\/10.1089\/thy.2010.0226","journal-title":"Thyroid"},{"key":"9705_CR44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1172\/JCI121277","volume":"129","author":"L Yehia","year":"2019","unstructured":"Yehia L, Ngeow J and Eng C (2019) PTEN-opathies: from biological insights to evidence-based precision medicine. J Clin Invest 129:452-464 https:\/\/doi.org\/10.1172\/JCI121277","journal-title":"J Clin Invest"},{"key":"9705_CR45","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.5858\/arpa.2018-0570-RA","volume":"143","author":"P Dinarvand","year":"2019","unstructured":"Dinarvand P, Davaro EP, Doan JV et al (2019) Familial Adenomatous Polyposis Syndrome: An Update and Review of Extraintestinal Manifestations. Arch Pathol Lab Med 143:1382-1398 https:\/\/doi.org\/10.5858\/arpa.2018-0570-RA","journal-title":"Arch Pathol Lab Med"},{"key":"9705_CR46","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/EJE-20-1120","volume":"184","author":"L Bouys","year":"2021","unstructured":"Bouys L and Bertherat J (2021) MANAGEMENT OF ENDOCRINE DISEASE: Carney complex: clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene. Eur J Endocrinol 184:R99-R109 https:\/\/doi.org\/10.1530\/EJE-20-1120","journal-title":"Eur J Endocrinol"},{"key":"9705_CR47","unstructured":"Oshima J, Martin GM and Hisama FM (1993) Werner Syndrome. GeneReviews((R))"},{"key":"9705_CR48","unstructured":"Yehia L and Eng C (1993) PTEN Hamartoma Tumor Syndrome. GeneReviews((R))"},{"key":"9705_CR49","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/hmg\/ddr459","volume":"21","author":"Y Ni","year":"2012","unstructured":"Ni Y, He X, Chen J et al (2012) Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD\/NAD-dependant destabilization of p53. Hum Mol Genet 21:300-10 https:\/\/doi.org\/10.1093\/hmg\/ddr459","journal-title":"Hum Mol Genet"},{"key":"9705_CR50","doi-asserted-by":"publisher","first-page":"R150","DOI":"10.1093\/hmg\/ddaa127","volume":"29","author":"L Yehia","year":"2020","unstructured":"Yehia L and Eng C (2020) PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation? Hum Mol Genet 29:R150-R157 https:\/\/doi.org\/10.1093\/hmg\/ddaa127","journal-title":"Hum Mol Genet"},{"key":"9705_CR51","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0002-9440(10)61155-8","volume":"160","author":"C Groves","year":"2002","unstructured":"Groves C, Lamlum H, Crabtree M et al (2002) Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160:2055-61 https:\/\/doi.org\/10.1016\/S0002-9440(10)61155-8","journal-title":"Am J Pathol"},{"key":"9705_CR52","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41379-018-0070-2","volume":"31","author":"JM Cameselle-Teijeiro","year":"2018","unstructured":"Cameselle-Teijeiro JM, Peteiro-Gonzalez D, Caneiro-Gomez J et al (2018) Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT\/beta-catenin pathway. Mod Pathol 31:1168-1179 https:\/\/doi.org\/10.1038\/s41379-018-0070-2","journal-title":"Mod Pathol"},{"key":"9705_CR53","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","volume":"24","author":"KAP Schultz","year":"2018","unstructured":"Schultz KAP, Williams GM, Kamihara J et al (2018) DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res 24:2251-2261 https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3089","journal-title":"Clin Cancer Res"},{"key":"9705_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejmg.2018.04.011","volume":"62","author":"JC Herriges","year":"2019","unstructured":"Herriges JC, Brown S, Longhurst M et al (2019) Identification of two 14q32 deletions involving DICER1 associated with the development of DICER1-related tumors. Eur J Med Genet 62:9-14 https:\/\/doi.org\/10.1016\/j.ejmg.2018.04.011","journal-title":"Eur J Med Genet"},{"key":"9705_CR55","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000509183","volume":"9","author":"S Canberk","year":"2021","unstructured":"Canberk S, Ferreira JC, Pereira L et al (2021) Analyzing the Role of DICER1 Germline Variations in Papillary Thyroid Carcinoma. Eur Thyroid J 9:296-303 https:\/\/doi.org\/10.1159\/000509183","journal-title":"Eur Thyroid J"},{"key":"9705_CR56","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMc1309730","volume":"370","author":"A Forlino","year":"2014","unstructured":"Forlino A, Vetro A, Garavelli L et al (2014) PRKACB and Carney complex. N Engl J Med 370:1065-7 https:\/\/doi.org\/10.1056\/NEJMc1309730","journal-title":"N Engl J Med"},{"key":"9705_CR57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/jmg.40.4.268","volume":"40","author":"L Matyakhina","year":"2003","unstructured":"Matyakhina L, Pack S, Kirschner LS et al (2003) Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 40:268-77 https:\/\/doi.org\/10.1136\/jmg.40.4.268","journal-title":"J Med Genet"},{"key":"9705_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/humu.23128","volume":"38","author":"K Yokote","year":"2017","unstructured":"Yokote K, Chanprasert S, Lee L et al (2017) WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational Prospects. Hum Mutat 38:7-15 https:\/\/doi.org\/10.1002\/humu.23128","journal-title":"Hum Mutat"},{"key":"9705_CR59","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12022-021-09683-0","volume":"32","author":"B Boyraz","year":"2021","unstructured":"Boyraz B, Sadow PM, Asa SL, Dias-Santagata D, Nose V and Mete O (2021) Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis. Endocr Pathol 32:327-335 https:\/\/doi.org\/10.1007\/s12022-021-09683-0","journal-title":"Endocr Pathol"},{"key":"9705_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12105-016-0708-7","volume":"10","author":"V Nose","year":"2016","unstructured":"Nose V (2016) Genodermatosis Affecting the Skin and Mucosa of the Head and Neck: Clinicopathologic, Genetic, and Molecular Aspect--PTEN-Hamartoma Tumor Syndrome\/Cowden Syndrome. Head Neck Pathol 10:131-8 https:\/\/doi.org\/10.1007\/s12105-016-0708-7","journal-title":"Head Neck Pathol"},{"key":"9705_CR61","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/PAS.0b013e31822fbc7d","volume":"35","author":"JA Barletta","year":"2011","unstructured":"Barletta JA, Bellizzi AM and Hornick JL (2011) Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome. Am J Surg Pathol 35:1505-11 https:\/\/doi.org\/10.1097\/PAS.0b013e31822fbc7d","journal-title":"Am J Surg Pathol"},{"key":"9705_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.600682","volume":"12","author":"A Srivastava","year":"2021","unstructured":"Srivastava A, Giangiobbe S, Skopelitou D et al (2021) Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer. Front Endocrinol (Lausanne) 12:600682 https:\/\/doi.org\/10.3389\/fendo.2021.600682","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9705_CR63","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1210\/jc.2016-2954","volume":"102","author":"NE Khan","year":"2017","unstructured":"Khan NE, Bauer AJ, Schultz KAP et al (2017) Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study. J Clin Endocrinol Metab 102:1614-1622 https:\/\/doi.org\/10.1210\/jc.2016-2954","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.annpat.2018.04.003","volume":"38","author":"L Ravella","year":"2018","unstructured":"Ravella L, Lopez J, Descotes F, Lifante JC, David C and Decaussin-Petrucci M (2018) [DICER1 mutated, solid\/trabecular thyroid papillary carcinoma in an 11-year-old child]. Ann Pathol 38:316-320 https:\/\/doi.org\/10.1016\/j.annpat.2018.04.003","journal-title":"Ann Pathol"},{"key":"9705_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","volume":"1","author":"PL Dahia","year":"2005","unstructured":"Dahia PL, Ross KN, Wright ME et al (2005) A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1:72-80 https:\/\/doi.org\/10.1371\/journal.pgen.0010008","journal-title":"PLoS Genet"},{"key":"9705_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/PAT.0b013e3283539932","volume":"44","author":"AJ Gill","year":"2012","unstructured":"Gill AJ (2012) Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology 44:285-92 https:\/\/doi.org\/10.1097\/PAT.0b013e3283539932","journal-title":"Pathology"},{"key":"9705_CR67","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/his.13277","volume":"72","author":"AJ Gill","year":"2018","unstructured":"Gill AJ (2018) Succinate dehydrogenase (SDH)-deficient neoplasia. Histopathology 72:106-116 https:\/\/doi.org\/10.1111\/his.13277","journal-title":"Histopathology"},{"key":"9705_CR68","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/PAS.0b013e3181d6150d","volume":"34","author":"AJ Gill","year":"2010","unstructured":"Gill AJ, Chou A, Vilain R et al (2010) Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol 34:636-44 https:\/\/doi.org\/10.1097\/PAS.0b013e3181d6150d","journal-title":"Am J Surg Pathol"},{"key":"9705_CR69","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1097\/PAS.0b013e3182260752","volume":"35","author":"M Miettinen","year":"2011","unstructured":"Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P and Lasota J (2011) Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 35:1712-21 https:\/\/doi.org\/10.1097\/PAS.0b013e3182260752","journal-title":"Am J Surg Pathol"},{"key":"9705_CR70","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/jc.2017-00165","volume":"102","author":"MS Elston","year":"2017","unstructured":"Elston MS, Sehgal S, Dray M et al (2017) A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation. J Clin Endocrinol Metab 102:1447-1450 https:\/\/doi.org\/10.1210\/jc.2017-00165","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00998-1","author":"TL Fuchs","year":"2021","unstructured":"Fuchs TL, Maclean F, Turchini J et al (2021) Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients. Mod Pathol https:\/\/doi.org\/10.1038\/s41379-021-00998-1","journal-title":"Mod Pathol"},{"key":"9705_CR72","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","volume":"34","author":"K Trpkov","year":"2021","unstructured":"Trpkov K, Hes O, Williamson SR et al (2021) New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 34:1392-1424 https:\/\/doi.org\/10.1038\/s41379-021-00779-w","journal-title":"Mod Pathol"},{"key":"9705_CR73","doi-asserted-by":"publisher","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","volume":"96","author":"E Korpershoek","year":"2011","unstructured":"Korpershoek E, Favier J, Gaal J et al (2011) SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab 96:E1472-6 https:\/\/doi.org\/10.1210\/jc.2011-1043","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR74","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/PAS.0b013e3182671155","volume":"37","author":"T Dwight","year":"2013","unstructured":"Dwight T, Benn DE, Clarkson A et al (2013) Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors. Am J Surg Pathol 37:226-33 https:\/\/doi.org\/10.1097\/PAS.0b013e3182671155","journal-title":"Am J Surg Pathol"},{"key":"9705_CR75","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/PAS.0000000000001415","volume":"44","author":"J Turchini","year":"2020","unstructured":"Turchini J and Gill AJ (2020) Morphologic Clues to Succinate Dehydrogenase (SDH) Deficiency in Pheochromocytomas and Paragangliomas. Am J Surg Pathol 44:422-424 https:\/\/doi.org\/10.1097\/PAS.0000000000001415","journal-title":"Am J Surg Pathol"},{"key":"9705_CR76","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1073\/pnas.1009199108","volume":"108","author":"KA Janeway","year":"2011","unstructured":"Janeway KA, Kim SY, Lodish M et al (2011) Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A 108:314-8 https:\/\/doi.org\/10.1073\/pnas.1009199108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9705_CR77","doi-asserted-by":"publisher","unstructured":"Gill AJ, Chou A, Vilain RE and Clifton-Bligh RJ (2011) \"Pediatric-type\" gastrointestinal stromal tumors are SDHB negative (\"type 2\") GISTs. Am J Surg Pathol 35:1245\u20137; author reply 1247\u20138 https:\/\/doi.org\/10.1097\/PAS.0b013e3182217b93","DOI":"10.1097\/PAS.0b013e3182217b93"},{"key":"9705_CR78","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/PAS.0b013e318227e7f4","volume":"35","author":"AJ Gill","year":"2011","unstructured":"Gill AJ, Pachter NS, Chou A et al (2011) Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol 35:1578-85 https:\/\/doi.org\/10.1097\/PAS.0b013e318227e7f4","journal-title":"Am J Surg Pathol"},{"key":"9705_CR79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/modpathol.2014.86","volume":"28","author":"SR Williamson","year":"2015","unstructured":"Williamson SR, Eble JN, Amin MB et al (2015) Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol 28:80-94 https:\/\/doi.org\/10.1038\/modpathol.2014.86","journal-title":"Mod Pathol"},{"key":"9705_CR80","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Hes O, Papathomas T et al (2014) Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol 38:1588-602 https:\/\/doi.org\/10.1097\/PAS.0000000000000292","journal-title":"Am J Surg Pathol"},{"key":"9705_CR81","doi-asserted-by":"publisher","first-page":"E710","DOI":"10.1210\/jc.2014-4297","volume":"100","author":"P Xekouki","year":"2015","unstructured":"Xekouki P, Szarek E, Bullova P et al (2015) Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice. J Clin Endocrinol Metab 100:E710-9 https:\/\/doi.org\/10.1210\/jc.2014-4297","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR82","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill AJ, Toon CW, Clarkson A et al (2014) Succinate dehydrogenase deficiency is rare in pituitary adenomas. Am J Surg Pathol 38:560-6 https:\/\/doi.org\/10.1097\/PAS.0000000000000149","journal-title":"Am J Surg Pathol"},{"key":"9705_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-13-0623","volume":"170","author":"TG Papathomas","year":"2014","unstructured":"Papathomas TG, Gaal J, Corssmit EP et al (2014) Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol 170:1-12 https:\/\/doi.org\/10.1530\/EJE-13-0623","journal-title":"Eur J Endocrinol"},{"key":"9705_CR84","doi-asserted-by":"publisher","first-page":"E1103","DOI":"10.1210\/jc.2013-1400","volume":"98","author":"T Dwight","year":"2013","unstructured":"Dwight T, Mann K, Benn DE et al (2013) Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma\/paraganglioma. J Clin Endocrinol Metab 98:E1103-8 https:\/\/doi.org\/10.1210\/jc.2013-1400","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/his.13945","volume":"75","author":"K Chatzopoulos","year":"2019","unstructured":"Chatzopoulos K, Fritchie KJ, Aubry MC, Carney JA, Folpe AL and Boland JM (2019) Loss of succinate dehydrogenase B immunohistochemical expression distinguishes pulmonary chondromas from hamartomas. Histopathology 75:825-832 https:\/\/doi.org\/10.1111\/his.13945","journal-title":"Histopathology"},{"key":"9705_CR86","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/jmedgenet-2018-105427","volume":"55","author":"DE Benn","year":"2018","unstructured":"Benn DE, Zhu Y, Andrews KA et al (2018) Bayesian approach to determining penetrance of pathogenic SDH variants. J Med Genet 55:729-734 https:\/\/doi.org\/10.1136\/jmedgenet-2018-105427","journal-title":"J Med Genet"},{"key":"9705_CR87","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/PAP.0000000000000227","volume":"26","author":"TG Papathomas","year":"2019","unstructured":"Papathomas TG and Nose V (2019) New and Emerging Biomarkers in Endocrine Pathology. Adv Anat Pathol 26:198-209 https:\/\/doi.org\/10.1097\/PAP.0000000000000227","journal-title":"Adv Anat Pathol"},{"key":"9705_CR88","doi-asserted-by":"publisher","unstructured":"Williamson SR, Gill AJ, Argani P et al (2020) Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer. Am J Surg Pathol 44:e47-e65 https:\/\/doi.org\/10.1097\/PAS.0000000000001476","DOI":"10.1097\/PAS.0000000000001476"},{"key":"9705_CR89","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1056\/NEJMc070010","volume":"357","author":"FH van Nederveen","year":"2007","unstructured":"van Nederveen FH, Korpershoek E, Lenders JW, de Krijger RR and Dinjens WN (2007) Somatic SDHB mutation in an extraadrenal pheochromocytoma. N Engl J Med 357:306-8 https:\/\/doi.org\/10.1056\/NEJMc070010","journal-title":"N Engl J Med"},{"key":"9705_CR90","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","volume":"10","author":"FH van Nederveen","year":"2009","unstructured":"van Nederveen FH, Gaal J, Favier J et al (2009) An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764-71 https:\/\/doi.org\/10.1016\/S1470-2045(09)70164-0","journal-title":"Lancet Oncol"},{"key":"9705_CR91","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12022-020-09631-4","volume":"31","author":"J Turchini","year":"2020","unstructured":"Turchini J and Gill AJ (2020) Hereditary Parathyroid Disease: Sometimes Pathologists Do Not Know What They Are Missing. Endocr Pathol 31:218-230 https:\/\/doi.org\/10.1007\/s12022-020-09631-4","journal-title":"Endocr Pathol"},{"key":"9705_CR92","doi-asserted-by":"publisher","first-page":"1761030","DOI":"10.1155\/2019\/1761030","volume":"2019","author":"F Torresan","year":"2019","unstructured":"Torresan F and Iacobone M (2019) Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature. Int J Endocrinol 2019:1761030 https:\/\/doi.org\/10.1155\/2019\/1761030","journal-title":"Int J Endocrinol"},{"key":"9705_CR93","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","volume":"143","author":"MS Sarquis","year":"2008","unstructured":"Sarquis MS, Silveira LG, Pimenta FJ et al (2008) Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery 143:630-40 https:\/\/doi.org\/10.1016\/j.surg.2007.12.012","journal-title":"Surgery"},{"key":"9705_CR94","unstructured":"Jackson CE, Norum RA, Boyd SB et al (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006\u201312; discussion 1012\u20133"},{"key":"9705_CR95","doi-asserted-by":"publisher","unstructured":"Mehta A, Patel D, Rosenberg A et al (2014) Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery 156:1315\u201324; discussion 1324\u20135 https:\/\/doi.org\/10.1016\/j.surg.2014.08.004","DOI":"10.1016\/j.surg.2014.08.004"},{"key":"9705_CR96","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00423-009-0511-y","volume":"394","author":"M Iacobone","year":"2009","unstructured":"Iacobone M, Masi G, Barzon L et al (2009) Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg 394:817-25 https:\/\/doi.org\/10.1007\/s00423-009-0511-y","journal-title":"Langenbecks Arch Surg"},{"key":"9705_CR97","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1677\/ERC-08-0066","volume":"15","author":"G Masi","year":"2008","unstructured":"Masi G, Barzon L, Iacobone M et al (2008) Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer 15:1115-26 https:\/\/doi.org\/10.1677\/ERC-08-0066","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR98","doi-asserted-by":"publisher","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"Bricaire L, Odou MF, Cardot-Bauters C et al (2013) Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab 98:E403-8 https:\/\/doi.org\/10.1210\/jc.2012-2789","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR99","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","volume":"43","author":"AJ Gill","year":"2019","unstructured":"Gill AJ, Lim G, Cheung VKY et al (2019) Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features. Am J Surg Pathol 43:35-46 https:\/\/doi.org\/10.1097\/PAS.0000000000001017","journal-title":"Am J Surg Pathol"},{"key":"9705_CR100","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1158\/1078-0432.CCR-17-0548","volume":"23","author":"JD Wasserman","year":"2017","unstructured":"Wasserman JD, Tomlinson GE, Druker H et al (2017) Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res 23:e123-e132 https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0548","journal-title":"Clin Cancer Res"},{"key":"9705_CR101","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A et al (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-80 https:\/\/doi.org\/10.1038\/ng1048","journal-title":"Nat Genet"},{"key":"9705_CR102","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill AJ, Clarkson A, Gimm O et al (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30:1140-9 https:\/\/doi.org\/10.1097\/01.pas.0000209827.39477.4f","journal-title":"Am J Surg Pathol"},{"key":"9705_CR103","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12022-013-9294-3","volume":"25","author":"AJ Gill","year":"2014","unstructured":"Gill AJ (2014) Understanding the genetic basis of parathyroid carcinoma. Endocr Pathol 25:30-4 https:\/\/doi.org\/10.1007\/s12022-013-9294-3","journal-title":"Endocr Pathol"},{"key":"9705_CR104","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41379-019-0252-6","volume":"32","author":"CC Juhlin","year":"2019","unstructured":"Juhlin CC, Nilsson IL, Lagerstedt-Robinson K et al (2019) Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center. Mod Pathol 32:1082-1094 https:\/\/doi.org\/10.1038\/s41379-019-0252-6","journal-title":"Mod Pathol"},{"key":"9705_CR105","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A et al (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94:434-41 https:\/\/doi.org\/10.1210\/jc.2008-1740","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR106","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-Mendez","year":"2011","unstructured":"Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663-7 https:\/\/doi.org\/10.1038\/ng.861","journal-title":"Nat Genet"},{"key":"9705_CR107","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/his.13402","volume":"72","author":"J Turchini","year":"2018","unstructured":"Turchini J, Cheung VKY, Tischler AS, De Krijger RR and Gill AJ (2018) Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology 72:97-105 https:\/\/doi.org\/10.1111\/his.13402","journal-title":"Histopathology"},{"key":"9705_CR108","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12022-018-9534-7","volume":"29","author":"VKY Cheung","year":"2018","unstructured":"Cheung VKY, Gill AJ and Chou A (2018) Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma. Endocr Pathol 29:169-175 https:\/\/doi.org\/10.1007\/s12022-018-9534-7","journal-title":"Endocr Pathol"},{"key":"9705_CR109","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1086\/379382","volume":"73","author":"XP Zhou","year":"2003","unstructured":"Zhou XP, Marsh DJ, Morrison CD et al (2003) Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase\/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet 73:1191-8 https:\/\/doi.org\/10.1086\/379382","journal-title":"Am J Hum Genet"},{"key":"9705_CR110","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/cncr.25445","volume":"117","author":"SC Huang","year":"2011","unstructured":"Huang SC, Lee JK, Smith EJ et al (2011) Evidence for an hMSH3 defect in familial hamartomatous polyps. Cancer 117:492-500 https:\/\/doi.org\/10.1002\/cncr.25445","journal-title":"Cancer"},{"key":"9705_CR111","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMoa1502449","volume":"373","author":"SK Gara","year":"2015","unstructured":"Gara SK, Jia L, Merino MJ et al (2015) Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer. N Engl J Med 373:448-55 https:\/\/doi.org\/10.1056\/NEJMoa1502449","journal-title":"N Engl J Med"},{"key":"9705_CR112","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40618-020-01286-6","volume":"44","author":"D Pasquali","year":"2021","unstructured":"Pasquali D, Torella A, Accardo G et al (2021) BROX haploinsufficiency in familial nonmedullary thyroid cancer. J Endocrinol Invest 44:165-171 https:\/\/doi.org\/10.1007\/s40618-020-01286-6","journal-title":"J Endocrinol Invest"},{"key":"9705_CR113","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/thy.2017.0312","volume":"28","author":"AD Bakhsh","year":"2018","unstructured":"Bakhsh AD, Ladas I, Hamshere ML et al (2018) An InDel in Phospholipase-C-B-1 Is Linked with Euthyroid Multinodular Goiter. Thyroid 28:891-901 https:\/\/doi.org\/10.1089\/thy.2017.0312","journal-title":"Thyroid"},{"key":"9705_CR114","doi-asserted-by":"publisher","unstructured":"Orois A, Gara SK, Mora M et al (2019) NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer. Genes (Basel) 10 https:\/\/doi.org\/10.3390\/genes10110899","DOI":"10.3390\/genes10110899"},{"key":"9705_CR115","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00268-004-7560-8","volume":"28","author":"GM Doherty","year":"2004","unstructured":"Doherty GM, Lairmore TC and DeBenedetti MK (2004) Multiple endocrine neoplasia type 1 parathyroid adenoma development over time. World J Surg 28:1139-42 https:\/\/doi.org\/10.1007\/s00268-004-7560-8","journal-title":"World J Surg"},{"key":"9705_CR116","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","volume":"386","author":"RV Thakker","year":"2014","unstructured":"Thakker RV (2014) Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol 386:2-15 https:\/\/doi.org\/10.1016\/j.mce.2013.08.002","journal-title":"Mol Cell Endocrinol"},{"key":"9705_CR117","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000371819","volume":"103","author":"MH Schernthaner-Reiter","year":"2016","unstructured":"Schernthaner-Reiter MH, Trivellin G and Stratakis CA (2016) MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics. Neuroendocrinology 103:18-31 https:\/\/doi.org\/10.1159\/000371819","journal-title":"Neuroendocrinology"},{"key":"9705_CR118","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJM198907273210402","volume":"321","author":"E Friedman","year":"1989","unstructured":"Friedman E, Sakaguchi K, Bale AE et al (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213-8 https:\/\/doi.org\/10.1056\/NEJM198907273210402","journal-title":"N Engl J Med"},{"key":"9705_CR119","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/cen.12714","volume":"84","author":"N Singh Ospina","year":"2016","unstructured":"Singh Ospina N, Sebo TJ, Thompson GB, Clarke BL and Young WF, Jr. (2016) Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literature. Clin Endocrinol (Oxf) 84:244-249 https:\/\/doi.org\/10.1111\/cen.12714","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9705_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.03.035","author":"JS Mathiesen","year":"2021","unstructured":"Mathiesen JS, Effraimidis G, Rossing M et al (2021) Multiple endocrine neoplasia type 2: A reveiw. Semin Cancer Biol https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.035","journal-title":"Semin Cancer Biol"},{"key":"9705_CR121","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/EC-20-0163","volume":"9","author":"LV Larsen","year":"2020","unstructured":"Larsen LV, Mirebeau-Prunier D, Imai T et al (2020) Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study. Endocr Connect 9:489-497 https:\/\/doi.org\/10.1530\/EC-20-0163","journal-title":"Endocr Connect"},{"key":"9705_CR122","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","volume":"257","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Hobbs MR, Buley ID et al (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257:18-26 https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01421.x","journal-title":"J Intern Med"},{"key":"9705_CR123","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.urology.2018.11.013","volume":"124","author":"CD Vocke","year":"2019","unstructured":"Vocke CD, Ricketts CJ, Ball MW et al (2019) CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors. Urology 124:91-97 https:\/\/doi.org\/10.1016\/j.urology.2018.11.013","journal-title":"Urology"},{"key":"9705_CR124","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jds.2019.12.007","volume":"15","author":"HM Ibrahem","year":"2020","unstructured":"Ibrahem HM (2020) Ossifying fibroma of the jaw bones in hyperparathyroidism-jaw tumor syndrome: Analysis of 24 cases retrieved from literatures. J Dent Sci 15:426-432 https:\/\/doi.org\/10.1016\/j.jds.2019.12.007","journal-title":"J Dent Sci"},{"key":"9705_CR125","first-page":"944","volume":"56","author":"J Szabo","year":"1995","unstructured":"Szabo J, Heath B, Hill VM et al (1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet 56:944-50","journal-title":"Am J Hum Genet"},{"key":"9705_CR126","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722-9 https:\/\/doi.org\/10.1056\/NEJMoa031237","journal-title":"N Engl J Med"},{"key":"9705_CR127","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Borsari S et al (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583-91 https:\/\/doi.org\/10.1210\/jc.2004-0294","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12022-018-9527-6","volume":"29","author":"LA Erickson","year":"2018","unstructured":"Erickson LA and Mete O (2018) Immunohistochemistry in Diagnostic Parathyroid Pathology. Endocr Pathol 29:113-129 https:\/\/doi.org\/10.1007\/s12022-018-9527-6","journal-title":"Endocr Pathol"},{"key":"9705_CR129","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.humpath.2020.07.008","volume":"110","author":"MD Williams","year":"2021","unstructured":"Williams MD, DeLellis RA, Erickson LA et al (2021) Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol 110:73-82 https:\/\/doi.org\/10.1016\/j.humpath.2020.07.008","journal-title":"Hum Pathol"},{"key":"9705_CR130","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","volume":"15","author":"F Castinetti","year":"2014","unstructured":"Castinetti F, Qi XP, Walz MK et al (2014) Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol 15:648-55 https:\/\/doi.org\/10.1016\/S1470-2045(14)70154-8","journal-title":"Lancet Oncol"},{"key":"9705_CR131","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s12020-020-02332-2","volume":"69","author":"V Amodru","year":"2020","unstructured":"Amodru V, Taieb D, Guerin C et al (2020) MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives. Endocrine 69:496-503 https:\/\/doi.org\/10.1007\/s12020-020-02332-2","journal-title":"Endocrine"},{"key":"9705_CR132","doi-asserted-by":"publisher","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","volume":"98","author":"S Thosani","year":"2013","unstructured":"Thosani S, Ayala-Ramirez M, Palmer L et al (2013) The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 98:E1813-9 https:\/\/doi.org\/10.1210\/jc.2013-1653","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR133","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","volume":"7","author":"F Castinetti","year":"2019","unstructured":"Castinetti F, Waguespack SG, Machens A et al (2019) Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol 7:213-220 https:\/\/doi.org\/10.1016\/S2213-8587(18)30336-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9705_CR134","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1530\/EJE-12-1106","volume":"168","author":"T Imai","year":"2013","unstructured":"Imai T, Uchino S, Okamoto T et al (2013) High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients. Eur J Endocrinol 168:683-7 https:\/\/doi.org\/10.1530\/EJE-12-1106","journal-title":"Eur J Endocrinol"},{"key":"9705_CR135","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/ases.12332","volume":"10","author":"M Yamasaki","year":"2017","unstructured":"Yamasaki M, Sato Y, Nomura T, Sato F, Uchino S and Mimata H (2017) Composite paraganglioma-ganglioneuroma concomitant with adrenal metastasis of medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 2B: A case report. Asian J Endosc Surg 10:66-69 https:\/\/doi.org\/10.1111\/ases.12332","journal-title":"Asian J Endosc Surg"},{"key":"9705_CR136","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","volume":"35","author":"JM Schreinemakers","year":"2011","unstructured":"Schreinemakers JM, Pieterman CR, Scholten A, Vriens MR, Valk GD and Rinkes IH (2011) The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg 35:1993-2005 https:\/\/doi.org\/10.1007\/s00268-011-1068-9","journal-title":"World J Surg"},{"key":"9705_CR137","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","volume":"255","author":"CR Pieterman","year":"2012","unstructured":"Pieterman CR, van Hulsteijn LT, den Heijer M et al (2012) Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg 255:1171-8 https:\/\/doi.org\/10.1097\/SLA.0b013e31824c5145","journal-title":"Ann Surg"},{"key":"9705_CR138","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-71 https:\/\/doi.org\/10.1210\/jcem.86.12.8070","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR139","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990-3011 https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR140","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMc1406028","volume":"371","author":"Dreijerink KM, Goudet P, Burgess JR, Valk GD and International Breast Cancer in MENSG","year":"2014","unstructured":"Dreijerink KM, Goudet P, Burgess JR, Valk GD and International Breast Cancer in MENSG (2014) Breast-cancer predisposition in multiple endocrine neoplasia type 1. N Engl J Med 371:583-4 https:\/\/doi.org\/10.1056\/NEJMc1406028","journal-title":"N Engl J Med"},{"key":"9705_CR141","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","volume":"17","author":"A Al-Salameh","year":"2021","unstructured":"Al-Salameh A, Cadiot G, Calender A, Goudet P and Chanson P (2021) Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol 17:207-224 https:\/\/doi.org\/10.1038\/s41574-021-00468-3","journal-title":"Nat Rev Endocrinol"},{"key":"9705_CR142","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-7819-9-6","volume":"9","author":"JE Griniatsos","year":"2011","unstructured":"Griniatsos JE, Dimitriou N, Zilos A et al (2011) Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene. World J Surg Oncol 9:6 https:\/\/doi.org\/10.1186\/1477-7819-9-6","journal-title":"World J Surg Oncol"},{"key":"9705_CR143","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/EJE-11-0679","volume":"166","author":"B Gatta-Cherifi","year":"2012","unstructured":"Gatta-Cherifi B, Chabre O, Murat A et al (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. Eur J Endocrinol 166:269-79 https:\/\/doi.org\/10.1530\/EJE-11-0679","journal-title":"Eur J Endocrinol"},{"key":"9705_CR144","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA, Jr., Asa SL, Dralle H et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25:567-610 https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"key":"9705_CR145","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/01.pas.0000166368.68459.99","volume":"29","author":"JL Hunt","year":"2005","unstructured":"Hunt JL, Carty SE, Yim JH, Murphy J and Barnes L (2005) Allelic loss in parathyroid neoplasia can help characterize malignancy. Am J Surg Pathol 29:1049-55","journal-title":"Am J Surg Pathol"},{"key":"9705_CR146","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12022-019-09592-3","volume":"30","author":"AM Silva-Figueroa","year":"2019","unstructured":"Silva-Figueroa AM, Bassett R, Jr., Christakis I et al (2019) Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. Endocr Pathol 30:285-296 https:\/\/doi.org\/10.1007\/s12022-019-09592-3","journal-title":"Endocr Pathol"},{"key":"9705_CR147","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12022-020-09656-9","volume":"32","author":"CC Juhlin","year":"2021","unstructured":"Juhlin CC and Erickson LA (2021) Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice. Endocr Pathol 32:17-34 https:\/\/doi.org\/10.1007\/s12022-020-09656-9","journal-title":"Endocr Pathol"},{"key":"9705_CR148","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.oraloncology.2005.11.019","volume":"42","author":"FJ Pimenta","year":"2006","unstructured":"Pimenta FJ, Gontijo Silveira LF, Tavares GC et al (2006) HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol 42:735-9 https:\/\/doi.org\/10.1016\/j.oraloncology.2005.11.019","journal-title":"Oral Oncol"},{"key":"9705_CR149","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1210\/jcem.85.4.6518","volume":"85","author":"CJ Haven","year":"2000","unstructured":"Haven CJ, Wong FK, van Dam EW et al (2000) A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 85:1449-54 https:\/\/doi.org\/10.1210\/jcem.85.4.6518","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR150","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1038\/onc.2017.43","volume":"36","author":"GV Walls","year":"2017","unstructured":"Walls GV, Stevenson M, Lines KE et al (2017) Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome. Oncogene 36:4025-4036 https:\/\/doi.org\/10.1038\/onc.2017.43","journal-title":"Oncogene"},{"key":"9705_CR151","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00401-013-1091-z","volume":"125","author":"AO Vortmeyer","year":"2013","unstructured":"Vortmeyer AO, Falke EA, Glasker S, Li J and Oldfield EH (2013) Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms. Acta Neuropathol 125:333-50 https:\/\/doi.org\/10.1007\/s00401-013-1091-z","journal-title":"Acta Neuropathol"},{"key":"9705_CR152","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jmedgenet-2017-104995","volume":"55","author":"JY Wang","year":"2018","unstructured":"Wang JY, Peng SH, Li T et al (2018) Risk factors for survival in patients with von Hippel-Lindau disease. J Med Genet 55:322-328 https:\/\/doi.org\/10.1136\/jmedgenet-2017-104995","journal-title":"J Med Genet"},{"key":"9705_CR153","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/bjophthalmol-2017-310884","volume":"102","author":"MLM Binderup","year":"2018","unstructured":"Binderup MLM, Stendell AS, Galanakis M, Moller HU, Kiilgaard JF and Bisgaard ML (2018) Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease. Br J Ophthalmol 102:942-947 https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310884","journal-title":"Br J Ophthalmol"},{"key":"9705_CR154","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jmg.33.2.120","volume":"33","author":"IR Maddock","year":"1996","unstructured":"Maddock IR, Moran A, Maher ER et al (1996) A genetic register for von Hippel-Lindau disease. J Med Genet 33:120-7 https:\/\/doi.org\/10.1136\/jmg.33.2.120","journal-title":"J Med Genet"},{"key":"9705_CR155","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000562","volume":"39","author":"AJ Adeniran","year":"2015","unstructured":"Adeniran AJ, Shuch B and Humphrey PA (2015) Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol 39:e1-e18 https:\/\/doi.org\/10.1097\/PAS.0000000000000562","journal-title":"Am J Surg Pathol"},{"key":"9705_CR156","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0003-2697(92)90449-h","volume":"205","author":"PA Furth","year":"1992","unstructured":"Furth PA, Shamay A, Wall RJ and Hennighausen L (1992) Gene transfer into somatic tissues by jet injection. Anal Biochem 205:365-8 https:\/\/doi.org\/10.1016\/0003-2697(92)90449-h","journal-title":"Anal Biochem"},{"key":"9705_CR157","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12032-019-1297-6","volume":"36","author":"JM Kennedy","year":"2019","unstructured":"Kennedy JM, Wang X, Plouffe KR et al (2019) Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series. Med Oncol 36:74 https:\/\/doi.org\/10.1007\/s12032-019-1297-6","journal-title":"Med Oncol"},{"key":"9705_CR158","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jama.277.18.1461","volume":"277","author":"TJ Manski","year":"1997","unstructured":"Manski TJ, Heffner DK, Glenn GM et al (1997) Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461-6 https:\/\/doi.org\/10.1001\/jama.277.18.1461","journal-title":"JAMA"},{"issue":"Suppl 1","key":"9705_CR159","doi-asserted-by":"publisher","first-page":"E673","DOI":"10.1002\/hed.24067","volume":"38","author":"B Bausch","year":"2016","unstructured":"Bausch B, Wellner U, Peyre M et al (2016) Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry. Head Neck 38 Suppl 1:E673-9 https:\/\/doi.org\/10.1002\/hed.24067","journal-title":"Head Neck"},{"key":"9705_CR160","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/00005392-199909010-00004","volume":"162","author":"MM Walther","year":"1999","unstructured":"Walther MM, Reiter R, Keiser HR et al (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162:659-64 https:\/\/doi.org\/10.1097\/00005392-199909010-00004","journal-title":"J Urol"},{"key":"9705_CR161","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0002-9440(10)65563-0","volume":"153","author":"IA Lubensky","year":"1998","unstructured":"Lubensky IA, Pack S, Ault D et al (1998) Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol 153:223-31 https:\/\/doi.org\/10.1016\/S0002-9440(10)65563-0","journal-title":"Am J Pathol"},{"key":"9705_CR162","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/PAS.0b013e3181967992","volume":"33","author":"M Perigny","year":"2009","unstructured":"Perigny M, Hammel P, Corcos O et al (2009) Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL\/HIF pathway proteins expression. Am J Surg Pathol 33:739-48 https:\/\/doi.org\/10.1097\/PAS.0b013e3181967992","journal-title":"Am J Surg Pathol"},{"key":"9705_CR163","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1053\/gast.2000.18143","volume":"119","author":"PR Hammel","year":"2000","unstructured":"Hammel PR, Vilgrain V, Terris B et al (2000) Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 119:1087-95 https:\/\/doi.org\/10.1053\/gast.2000.18143","journal-title":"Gastroenterology"},{"key":"9705_CR164","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","volume":"23","author":"S Richard","year":"2013","unstructured":"Richard S, Gardie B, Couve S and Gad S (2013) Von Hippel-Lindau: how a rare disease illuminates cancer biology. Semin Cancer Biol 23:26-37 https:\/\/doi.org\/10.1016\/j.semcancer.2012.05.005","journal-title":"Semin Cancer Biol"},{"key":"9705_CR165","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00428-013-1465-6","volume":"463","author":"H Gucer","year":"2013","unstructured":"Gucer H, Szentgyorgyi E, Ezzat S, Asa SL and Mete O (2013) Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease. Virchows Arch 463:593-7 https:\/\/doi.org\/10.1007\/s00428-013-1465-6","journal-title":"Virchows Arch"},{"key":"9705_CR166","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/00000478-200110000-00017","volume":"25","author":"PA Sinkre","year":"2001","unstructured":"Sinkre PA, Murakata L, Rabin L, Hoang MP and Albores-Saavedra J (2001) Clear cell carcinoid tumor of the gallbladder: another distinctive manifestation of von Hippel-Lindau disease. Am J Surg Pathol 25:1334-9 https:\/\/doi.org\/10.1097\/00000478-200110000-00017","journal-title":"Am J Surg Pathol"},{"key":"9705_CR167","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1043\/1543-2165-134.4.630","volume":"134","author":"KJ Odrzywolski","year":"2010","unstructured":"Odrzywolski KJ and Mukhopadhyay S (2010) Papillary cystadenoma of the epididymis. Arch Pathol Lab Med 134:630-3 https:\/\/doi.org\/10.1043\/1543-2165-134.4.630","journal-title":"Arch Pathol Lab Med"},{"key":"9705_CR168","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/PGP.0b013e318228f577","volume":"31","author":"A Brady","year":"2012","unstructured":"Brady A, Nayar A, Cross P et al (2012) A detailed immunohistochemical analysis of 2 cases of papillary cystadenoma of the broad ligament: an extremely rare neoplasm characteristic of patients with von hippel-lindau disease. Int J Gynecol Pathol 31:133-40 https:\/\/doi.org\/10.1097\/PGP.0b013e318228f577","journal-title":"Int J Gynecol Pathol"},{"key":"9705_CR169","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00404-010-1386-4","volume":"282","author":"DB Zanotelli","year":"2010","unstructured":"Zanotelli DB, Bruder E, Wight E and Troeger C (2010) Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of Von Hippel-Lindau disease. Arch Gynecol Obstet 282:343-6 https:\/\/doi.org\/10.1007\/s00404-010-1386-4","journal-title":"Arch Gynecol Obstet"},{"key":"9705_CR170","unstructured":"Binderup ML, Bisgaard ML, Harbud V et al (2013) Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition. Dan Med J 60:B4763"},{"key":"9705_CR171","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","volume":"23","author":"SP Rednam","year":"2017","unstructured":"Rednam SP, Erez A, Druker H et al (2017) Von Hippel-Lindau and Hereditary Pheochromocytoma\/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res 23:e68-e75 https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0547","journal-title":"Clin Cancer Res"},{"key":"9705_CR172","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s11605-009-1123-0","volume":"14","author":"D Relles","year":"2010","unstructured":"Relles D, Baek J, Witkiewicz A and Yeo CJ (2010) Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases. J Gastrointest Surg 14:1052-61 https:\/\/doi.org\/10.1007\/s11605-009-1123-0","journal-title":"J Gastrointest Surg"},{"key":"9705_CR173","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/00000478-198910000-00002","volume":"13","author":"AP Burke","year":"1989","unstructured":"Burke AP, Federspiel BH, Sobin LH, Shekitka KM and Helwig EB (1989) Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol 13:828-37 https:\/\/doi.org\/10.1097\/00000478-198910000-00002","journal-title":"Am J Surg Pathol"},{"key":"9705_CR174","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1677\/ERC-07-0157","volume":"15","author":"N Garbrecht","year":"2008","unstructured":"Garbrecht N, Anlauf M, Schmitt A et al (2008) Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocr Relat Cancer 15:229-41 https:\/\/doi.org\/10.1677\/ERC-07-0157","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR175","first-page":"633","volume":"9","author":"GH Sakorafas","year":"2008","unstructured":"Sakorafas GH, Giannopoulos GA, Parasi A et al (2008) Large somatostatin-producing endocrine carcinoma of the ampulla of vater in association with GIST in a patient with von Recklinghausen's disease. Case report and review of the literature. JOP 9:633-9","journal-title":"JOP"},{"key":"9705_CR176","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1365-2559.1987.tb01877.x","volume":"11","author":"M Stephens","year":"1987","unstructured":"Stephens M, Williams GT, Jasani B and Williams ED (1987) Synchronous duodenal neuroendocrine tumours in von Recklinghausen's disease--a case report of co-existing gangliocytic paraganglioma and somatostatin-rich glandular carcinoid. Histopathology 11:1331-40 https:\/\/doi.org\/10.1111\/j.1365-2559.1987.tb01877.x","journal-title":"Histopathology"},{"key":"9705_CR177","first-page":"64","volume":"11","author":"L Deschamps","year":"2010","unstructured":"Deschamps L, Dokmak S, Guedj N, Ruszniewski P, Sauvanet A and Couvelard A (2010) Mixed endocrine somatostatinoma of the ampulla of vater associated with a neurofibromatosis type 1: a case report and review of the literature. JOP 11:64-8","journal-title":"JOP"},{"key":"9705_CR178","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fgene.2020.00395","volume":"11","author":"C Gregorio","year":"2020","unstructured":"Gregorio C, Rosset C, Alves LDS et al (2020) Synchronous Periampullary Tumors in a Patient With Pancreas Divisum and Neurofibromatosis Type 1. Front Genet 11:395 https:\/\/doi.org\/10.3389\/fgene.2020.00395","journal-title":"Front Genet"},{"key":"9705_CR179","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1530\/ERC-13-0046","volume":"20","author":"J Welander","year":"2013","unstructured":"Welander J, Soderkvist P and Gimm O (2013) The NF1 gene: a frequent mutational target in sporadic pheochromocytomas and beyond. Endocr Relat Cancer 20:C13-7 https:\/\/doi.org\/10.1530\/ERC-13-0046","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR180","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/modpathol.3880513","volume":"15","author":"N Kimura","year":"2002","unstructured":"Kimura N, Watanabe T, Fukase M, Wakita A, Noshiro T and Kimura I (2002) Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease. Mod Pathol 15:183-8 https:\/\/doi.org\/10.1038\/modpathol.3880513","journal-title":"Mod Pathol"},{"key":"9705_CR181","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","volume":"88","author":"MH Tan","year":"2011","unstructured":"Tan MH, Mester J, Peterson C et al (2011) A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 88:42-56 https:\/\/doi.org\/10.1016\/j.ajhg.2010.11.013","journal-title":"Am J Hum Genet"},{"key":"9705_CR182","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10689-016-9892-6","volume":"15","author":"JO Scapineli","year":"2016","unstructured":"Scapineli JO, Ceolin L, Punales MK, Dora JM and Maia AL (2016) MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics. Fam Cancer 15:625-33 https:\/\/doi.org\/10.1007\/s10689-016-9892-6","journal-title":"Fam Cancer"},{"key":"9705_CR183","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1089\/thy.2009.0021","volume":"19","author":"AE Rothberg","year":"2009","unstructured":"Rothberg AE, Raymond VM, Gruber SB and Sisson J (2009) Familial medullary thyroid carcinoma associated with cutaneous lichen amyloidosis. Thyroid 19:651-5 https:\/\/doi.org\/10.1089\/thy.2009.0021","journal-title":"Thyroid"},{"key":"9705_CR184","doi-asserted-by":"publisher","first-page":"33993","DOI":"10.18632\/oncotarget.4992","volume":"6","author":"XP Qi","year":"2015","unstructured":"Qi XP, Zhao JQ, Chen ZG et al (2015) RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D. Oncotarget 6:33993-4003 https:\/\/doi.org\/10.18632\/oncotarget.4992","journal-title":"Oncotarget"},{"key":"9705_CR185","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1530\/EC-18-0220","volume":"7","author":"XP Qi","year":"2018","unstructured":"Qi XP, Peng JZ, Yang XW et al (2018) The RET C611Y mutation causes MEN 2A and associated cutaneous. Endocr Connect 7:998-1005 https:\/\/doi.org\/10.1530\/EC-18-0220","journal-title":"Endocr Connect"},{"key":"9705_CR186","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jamadermatol.2017.3959","volume":"153","author":"V Alegria-Landa","year":"2017","unstructured":"Alegria-Landa V, Jo-Velasco M, Robledo M and Requena L (2017) Dermal Hyperneury and Multiple Sclerotic Fibromas in Multiple Endocrine Neoplasia Type 2A Syndrome. JAMA Dermatol 153:1298-1301 https:\/\/doi.org\/10.1001\/jamadermatol.2017.3959","journal-title":"JAMA Dermatol"},{"key":"9705_CR187","first-page":"249","volume":"40","author":"MF Robinson","year":"1992","unstructured":"Robinson MF, Furst EJ, Nunziata V et al (1992) Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2. Henry Ford Hosp Med J 40:249-52","journal-title":"Henry Ford Hosp Med J"},{"key":"9705_CR188","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/07357907.2018.1430813","volume":"36","author":"XP Qi","year":"2018","unstructured":"Qi XP, Zhao JQ, Cao ZL et al (2018) The Clinical Spectrum of Multiple Endocrine Neoplasia Type 2A with Cutaneous Lichen Amyloidosis in Ethnic Han Chinese. Cancer Invest 36:141-151 https:\/\/doi.org\/10.1080\/07357907.2018.1430813","journal-title":"Cancer Invest"},{"key":"9705_CR189","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1530\/eje.0.1390410","volume":"139","author":"HJ Karga","year":"1998","unstructured":"Karga HJ, Karayianni MK, Linos DA, Tseleni SC, Karaiskos KD and Papapetrou PD (1998) Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma. Eur J Endocrinol 139:410-5 https:\/\/doi.org\/10.1530\/eje.0.1390410","journal-title":"Eur J Endocrinol"},{"key":"9705_CR190","first-page":"147","volume":"37","author":"DT Donovan","year":"1989","unstructured":"Donovan DT, Levy ML, Furst EJ et al (1989) Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant. Henry Ford Hosp Med J 37:147-50","journal-title":"Henry Ford Hosp Med J"},{"key":"9705_CR191","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12022-015-9390-7","volume":"26","author":"LA Erickson","year":"2015","unstructured":"Erickson LA, Vrana JA, Theis J et al (2015) Analysis of Amyloid in Medullary Thyroid Carcinoma by Mass Spectrometry-Based Proteomic Analysis. Endocr Pathol 26:291-5 https:\/\/doi.org\/10.1007\/s12022-015-9390-7","journal-title":"Endocr Pathol"},{"key":"9705_CR192","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-111-10-802","volume":"111","author":"RF Gagel","year":"1989","unstructured":"Gagel RF, Levy ML, Donovan DT, Alford BR, Wheeler T and Tschen JA (1989) Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med 111:802-6 https:\/\/doi.org\/10.7326\/0003-4819-111-10-802","journal-title":"Ann Intern Med"},{"key":"9705_CR193","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/his.13941","volume":"75","author":"E Ieremia","year":"2019","unstructured":"Ieremia E, Marusic Z, Mudaliar V et al (2019) Expanding the clinical spectrum of dermal hyperneury: report of nine new cases and a review of the literature. Histopathology 75:738-745 https:\/\/doi.org\/10.1111\/his.13941","journal-title":"Histopathology"},{"key":"9705_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28056","volume":"67","author":"A Redlich","year":"2020","unstructured":"Redlich A, Lessel L, Petrou A, Mier P and Vorwerk P (2020) Multiple endocrine neoplasia type 2B: Frequency of physical stigmata-Results of the GPOH-MET registry. Pediatr Blood Cancer 67:e28056 https:\/\/doi.org\/10.1002\/pbc.28056","journal-title":"Pediatr Blood Cancer"},{"key":"9705_CR195","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/1523-1747.ep12500083","volume":"79","author":"RK Winkelmann","year":"1982","unstructured":"Winkelmann RK and Carney JA (1982) Cutaneous neuropathology in multiple endocrine neoplasia, type 2b. J Invest Dermatol 79:307-12 https:\/\/doi.org\/10.1111\/1523-1747.ep12500083","journal-title":"J Invest Dermatol"},{"key":"9705_CR196","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clindermatol.2020.10.008","volume":"39","author":"Z Marusic","year":"2021","unstructured":"Marusic Z, Korsa L and Calonje E (2021) Dermal hyperneury. Clin Dermatol 39:291-294 https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.008","journal-title":"Clin Dermatol"},{"key":"9705_CR197","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s1092-9134(99)80011-2","volume":"3","author":"HR Harach","year":"1999","unstructured":"Harach HR, Soubeyran I, Brown A, Bonneau D and Longy M (1999) Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 3:331-40 https:\/\/doi.org\/10.1016\/s1092-9134(99)80011-2","journal-title":"Ann Diagn Pathol"},{"key":"9705_CR198","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1210\/jc.2010-1315","volume":"96","author":"JR Smith","year":"2011","unstructured":"Smith JR, Marqusee E, Webb S et al (2011) Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome. J Clin Endocrinol Metab 96:34-7 https:\/\/doi.org\/10.1210\/jc.2010-1315","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR199","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.surg.2012.08.055","volume":"152","author":"M Milas","year":"2012","unstructured":"Milas M, Mester J, Metzger R et al (2012) Should patients with Cowden syndrome undergo prophylactic thyroidectomy? Surgery 152:1201-10 https:\/\/doi.org\/10.1016\/j.surg.2012.08.055","journal-title":"Surgery"},{"key":"9705_CR200","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/hed.22971","volume":"35","author":"JE Hall","year":"2013","unstructured":"Hall JE, Abdollahian DJ and Sinard RJ (2013) Thyroid disease associated with Cowden syndrome: A meta-analysis. Head Neck 35:1189-94 https:\/\/doi.org\/10.1002\/hed.22971","journal-title":"Head Neck"},{"key":"9705_CR201","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1309\/AJCP84INGJUVTBME","volume":"144","author":"J Cameselle-Teijeiro","year":"2015","unstructured":"Cameselle-Teijeiro J, Fachal C, Cabezas-Agricola JM et al (2015) Thyroid Pathology Findings in Cowden Syndrome: A Clue for the Diagnosis of the PTEN Hamartoma Tumor Syndrome. Am J Clin Pathol 144:322-8 https:\/\/doi.org\/10.1309\/AJCP84INGJUVTBME","journal-title":"Am J Clin Pathol"},{"key":"9705_CR202","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000506422","volume":"9","author":"T Szabo Yamashita","year":"2020","unstructured":"Szabo Yamashita T, Baky FJ, McKenzie TJ et al (2020) Occurrence and Natural History of Thyroid Cancer in Patients with Cowden Syndrome. Eur Thyroid J 9:243-246 https:\/\/doi.org\/10.1159\/000506422","journal-title":"Eur Thyroid J"},{"key":"9705_CR203","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4274\/Jcrpe.984","volume":"5","author":"V Peiretti","year":"2013","unstructured":"Peiretti V, Mussa A, Feyles F et al (2013) Thyroid involvement in two patients with Bannayan-Riley-Ruvalcaba syndrome. J Clin Res Pediatr Endocrinol 5:261-5 https:\/\/doi.org\/10.4274\/Jcrpe.984","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"9705_CR204","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1385\/ep:15:1:55","volume":"15","author":"E Zambrano","year":"2004","unstructured":"Zambrano E, Holm I, Glickman J et al (2004) Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes. Endocr Pathol 15:55-64 https:\/\/doi.org\/10.1385\/ep:15:1:55","journal-title":"Endocr Pathol"},{"key":"9705_CR205","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1210\/jc.2016-2043","volume":"101","author":"S Uchino","year":"2016","unstructured":"Uchino S, Ishikawa H, Miyauchi A et al (2016) Age- and Gender-Specific Risk of Thyroid Cancer in Patients With Familial Adenomatous Polyposis. J Clin Endocrinol Metab 101:4611-4617 https:\/\/doi.org\/10.1210\/jc.2016-2043","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR206","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2559.1994.tb01374.x","volume":"25","author":"HR Harach","year":"1994","unstructured":"Harach HR, Williams GT and Williams ED (1994) Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 25:549-61 https:\/\/doi.org\/10.1111\/j.1365-2559.1994.tb01374.x","journal-title":"Histopathology"},{"key":"9705_CR207","first-page":"400","volume":"12","author":"J Cameselle-Teijeiro","year":"1999","unstructured":"Cameselle-Teijeiro J and Chan JK (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400-11","journal-title":"Mod Pathol"},{"key":"9705_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32074\/1591-951X-66-18","volume":"111","author":"JM Cameselle-Teijeiro","year":"2019","unstructured":"Cameselle-Teijeiro JM and Sobrinho-Simoes M (2019) Cribriform-morular variant of thyroid carcinoma. Pathologica 111:1-3 https:\/\/doi.org\/10.32074\/1591-951X-66-18","journal-title":"Pathologica"},{"key":"9705_CR209","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1309\/AJCP7ULS0VSISBEB","volume":"131","author":"J Cameselle-Teijeiro","year":"2009","unstructured":"Cameselle-Teijeiro J, Menasce LP, Yap BK et al (2009) Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. Am J Clin Pathol 131:134-42 https:\/\/doi.org\/10.1309\/AJCP7ULS0VSISBEB","journal-title":"Am J Clin Pathol"},{"key":"9705_CR210","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/1066896912473355","volume":"21","author":"T Nakazawa","year":"2013","unstructured":"Nakazawa T, Celestino R, Machado JC et al (2013) Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. Int J Surg Pathol 21:379-89 https:\/\/doi.org\/10.1177\/1066896912473355","journal-title":"Int J Surg Pathol"},{"key":"9705_CR211","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1066896918796946","volume":"27","author":"J Corean","year":"2019","unstructured":"Corean J, Furtado LV, Kadri S, Segal JP and Emerson LL (2019) Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis. Int J Surg Pathol 27:294-304 https:\/\/doi.org\/10.1177\/1066896918796946","journal-title":"Int J Surg Pathol"},{"key":"9705_CR212","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/pin.12728","volume":"68","author":"H Tsuji","year":"2018","unstructured":"Tsuji H, Yasuoka H, Nakamura Y et al (2018) Aggressive cribriform-morular variant of papillary thyroid carcinoma: Report of an unusual case with pulmonary metastasis displaying poorly differentiated features. Pathol Int 68:700-705 https:\/\/doi.org\/10.1111\/pin.12728","journal-title":"Pathol Int"},{"key":"9705_CR213","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12022-016-9454-3","volume":"28","author":"EJ Oh","year":"2017","unstructured":"Oh EJ, Lee S, Bae JS, Kim Y, Jeon S and Jung CK (2017) TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma. Endocr Pathol 28:49-53 https:\/\/doi.org\/10.1007\/s12022-016-9454-3","journal-title":"Endocr Pathol"},{"key":"9705_CR214","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1210\/jcem.82.7.4079","volume":"82","author":"CA Stratakis","year":"1997","unstructured":"Stratakis CA, Courcoutsakis NA, Abati A et al (1997) Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82:2037-43 https:\/\/doi.org\/10.1210\/jcem.82.7.4079","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR215","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/PAS.0000000000000975","volume":"42","author":"JA Carney","year":"2018","unstructured":"Carney JA, Lyssikatos C, Seethala RR et al (2018) The Spectrum of Thyroid Gland Pathology in Carney Complex: The Importance of Follicular Carcinoma. Am J Surg Pathol 42:587-594 https:\/\/doi.org\/10.1097\/PAS.0000000000000975","journal-title":"Am J Surg Pathol"},{"key":"9705_CR216","unstructured":"Stratakis CA and Raygada M (1993) Carney Complex. GeneReviews((R))"},{"key":"9705_CR217","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40792-018-0438-z","volume":"4","author":"S Hattori","year":"2018","unstructured":"Hattori S, Yamane Y, Shimomura R et al (2018) Carney complex: a case with thyroid follicular adenoma without a PRKAR1A mutation. Surg Case Rep 4:34 https:\/\/doi.org\/10.1186\/s40792-018-0438-z","journal-title":"Surg Case Rep"},{"key":"9705_CR218","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12253-012-9502-3","volume":"18","author":"C Halaszlaki","year":"2012","unstructured":"Halaszlaki C, Takacs I, Butz H, Patocs A and Lakatos P (2012) Novel genetic mutation in the background of Carney complex. Pathol Oncol Res 18:149-52 https:\/\/doi.org\/10.1007\/s12253-012-9502-3","journal-title":"Pathol Oncol Res"},{"key":"9705_CR219","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1345::AID-CNCR18>3.0.CO;2-#","volume":"85","author":"Y Ishikawa","year":"1999","unstructured":"Ishikawa Y, Sugano H, Matsumoto T, Furuichi Y, Miller RW and Goto M (1999) Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer 85:1345-52","journal-title":"Cancer"},{"key":"9705_CR220","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12022-012-9219-6","volume":"23","author":"DA Winer","year":"2012","unstructured":"Winer DA, Winer S, Rotstein L, Asa SL and Mete O (2012) Villous papillary thyroid carcinoma: a variant associated with marfan syndrome. Endocr Pathol 23:254-9 https:\/\/doi.org\/10.1007\/s12022-012-9219-6","journal-title":"Endocr Pathol"},{"key":"9705_CR221","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00268-006-0847-1","volume":"31","author":"RS Sippel","year":"2007","unstructured":"Sippel RS, Caron NR and Clark OH (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924-33 https:\/\/doi.org\/10.1007\/s00268-006-0847-1","journal-title":"World J Surg"},{"key":"9705_CR222","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.surg.2008.08.004","volume":"145","author":"Y Ito","year":"2009","unstructured":"Ito Y, Kakudo K, Hirokawa M et al (2009) Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery 145:100-5 https:\/\/doi.org\/10.1016\/j.surg.2008.08.004","journal-title":"Surgery"},{"key":"9705_CR223","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/thy.2009.0406","volume":"21","author":"E Robenshtok","year":"2011","unstructured":"Robenshtok E, Tzvetov G, Grozinsky-Glasberg S et al (2011) Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid 21:43-8 https:\/\/doi.org\/10.1089\/thy.2009.0406","journal-title":"Thyroid"},{"key":"9705_CR224","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/thy.2010.0256","volume":"21","author":"W Moses","year":"2011","unstructured":"Moses W, Weng J and Kebebew E (2011) Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid 21:367-71 https:\/\/doi.org\/10.1089\/thy.2010.0256","journal-title":"Thyroid"},{"key":"9705_CR225","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1089\/thy.2011.0163","volume":"22","author":"YJ Park","year":"2012","unstructured":"Park YJ, Ahn HY, Choi HS, Kim KW, Park DJ and Cho BY (2012) The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid 22:356-62 https:\/\/doi.org\/10.1089\/thy.2011.0163","journal-title":"Thyroid"},{"key":"9705_CR226","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s00268-020-05473-7","volume":"44","author":"YS Kim","year":"2020","unstructured":"Kim YS, Seo M, Park SH, Ju SY and Kim ES (2020) Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer? World J Surg 44:3022-3027 https:\/\/doi.org\/10.1007\/s00268-020-05473-7","journal-title":"World J Surg"},{"key":"9705_CR227","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1210\/jcem.82.2.3789","volume":"82","author":"JR Burgess","year":"1997","unstructured":"Burgess JR, Duffield A, Wilkinson SJ et al (1997) Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 82:345-8 https:\/\/doi.org\/10.1210\/jcem.82.2.3789","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR228","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1158\/0008-5472.CAN-19-0721","volume":"79","author":"DV Bann","year":"2019","unstructured":"Bann DV, Jin Q, Sheldon KE et al (2019) Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer. Cancer Res 79:5490-5499 https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0721","journal-title":"Cancer Res"},{"key":"9705_CR229","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.589340","volume":"11","author":"V Cirello","year":"2020","unstructured":"Cirello V, Colombo C, Karapanou O, Pogliaghi G, Persani L and Fugazzola L (2020) Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers. Front Endocrinol (Lausanne) 11:589340 https:\/\/doi.org\/10.3389\/fendo.2020.589340","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9705_CR230","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12020-014-0470-0","volume":"49","author":"JS Pereira","year":"2015","unstructured":"Pereira JS, da Silva JG, Tomaz RA et al (2015) Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC). Endocrine 49:204-14 https:\/\/doi.org\/10.1007\/s12020-014-0470-0","journal-title":"Endocrine"},{"key":"9705_CR231","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1089\/thy.2019.0774","volume":"30","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Yu T, Chen L et al (2020) A Germline CHEK2 Mutation in a Family with Papillary Thyroid Cancer. Thyroid 30:924-930 https:\/\/doi.org\/10.1089\/thy.2019.0774","journal-title":"Thyroid"},{"key":"9705_CR232","doi-asserted-by":"publisher","unstructured":"Gasior-Perczak D, Kowalik A, Walczyk A et al (2019) Coexisting Germline CHEK2 and Somatic BRAF(V600E) Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course. Cancers (Basel) 11 https:\/\/doi.org\/10.3390\/cancers11111744","DOI":"10.3390\/cancers11111744"},{"key":"9705_CR233","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1677\/ERC-07-0214","volume":"15","author":"BM Cavaco","year":"2008","unstructured":"Cavaco BM, Batista PF, Martins C et al (2008) Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC\/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15:207-15 https:\/\/doi.org\/10.1677\/ERC-07-0214","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR234","doi-asserted-by":"publisher","unstructured":"Srivastava A, Kumar A, Giangiobbe S et al (2019) Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK\/ERK and PI3K\/AKT Signaling Pathways. Biomolecules 9 https:\/\/doi.org\/10.3390\/biom9100605","DOI":"10.3390\/biom9100605"},{"key":"9705_CR235","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/thy.2011.0192","volume":"22","author":"H Mazeh","year":"2012","unstructured":"Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H and Sippel RS (2012) In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid 22:3-8 https:\/\/doi.org\/10.1089\/thy.2011.0192","journal-title":"Thyroid"},{"key":"9705_CR236","doi-asserted-by":"publisher","unstructured":"Alsanea O, Wada N, Ain K et al (2000) Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043\u201350; discussion 1050\u20131 https:\/\/doi.org\/10.1067\/msy.2000.110848","DOI":"10.1067\/msy.2000.110848"},{"key":"9705_CR237","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1089\/thy.2005.15.588","volume":"15","author":"C Sturgeon","year":"2005","unstructured":"Sturgeon C and Clark OH (2005) Familial nonmedullary thyroid cancer. Thyroid 15:588-93 https:\/\/doi.org\/10.1089\/thy.2005.15.588","journal-title":"Thyroid"},{"key":"9705_CR238","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2015.00117","volume":"6","author":"M Tavarelli","year":"2015","unstructured":"Tavarelli M, Russo M, Terranova R et al (2015) Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families. Front Endocrinol (Lausanne) 6:117 https:\/\/doi.org\/10.3389\/fendo.2015.00117","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9705_CR239","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1677\/ERC-08-0080","volume":"15","author":"M Capezzone","year":"2008","unstructured":"Capezzone M, Marchisotta S, Cantara S et al (2008) Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075-81 https:\/\/doi.org\/10.1677\/ERC-08-0080","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR240","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s002680010233","volume":"24","author":"TJ Musholt","year":"2000","unstructured":"Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH and Klempnauer J (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 24:1409-17 https:\/\/doi.org\/10.1007\/s002680010233","journal-title":"World J Surg"},{"key":"9705_CR241","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1677\/erc.1.01138","volume":"13","author":"A Bakhsh","year":"2006","unstructured":"Bakhsh A, Kirov G, Gregory JW, Williams ED and Ludgate M (2006) A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. Endocr Relat Cancer 13:475-83 https:\/\/doi.org\/10.1677\/erc.1.01138","journal-title":"Endocr Relat Cancer"},{"key":"9705_CR242","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12020-020-02252-1","volume":"68","author":"D Williams","year":"2020","unstructured":"Williams D (2020) Inherited thyroid tumours. Endocrine 68:271-273 https:\/\/doi.org\/10.1007\/s12020-020-02252-1","journal-title":"Endocrine"},{"key":"9705_CR243","doi-asserted-by":"crossref","unstructured":"Neurofibromatosis (1988) Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575\u20138.\u00a0PMID: 3128965","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"9705_CR244","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.surg.2009.09.012","volume":"146","author":"I Suh","year":"2009","unstructured":"Suh I, Filetti S, Vriens MR et al (2009) Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery 146:1073-80 https:\/\/doi.org\/10.1016\/j.surg.2009.09.012","journal-title":"Surgery"},{"key":"9705_CR245","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1210\/jcem.85.5.6557","volume":"85","author":"CD Malchoff","year":"2000","unstructured":"Malchoff CD, Sarfarazi M, Tendler B et al (2000) Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 85:1758-64 https:\/\/doi.org\/10.1210\/jcem.85.5.6557","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR246","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12022-020-09607-4","volume":"31","author":"M Sarquis","year":"2020","unstructured":"Sarquis M, Moraes DC, Bastos-Rodrigues L et al (2020) Germline Mutations in Familial Papillary Thyroid Cancer. Endocr Pathol 31:14-20 https:\/\/doi.org\/10.1007\/s12022-020-09607-4","journal-title":"Endocr Pathol"},{"key":"9705_CR247","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/jmg.2003.017350","volume":"41","author":"JD McKay","year":"2004","unstructured":"McKay JD, Thompson D, Lesueur F et al (2004) Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. J Med Genet 41:407-12 https:\/\/doi.org\/10.1136\/jmg.2003.017350","journal-title":"J Med Genet"},{"key":"9705_CR248","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10689-007-9160-x","volume":"7","author":"HJ Prazeres","year":"2008","unstructured":"Prazeres HJ, Rodrigues F, Soares P et al (2008) Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Fam Cancer 7:141-9 https:\/\/doi.org\/10.1007\/s10689-007-9160-x","journal-title":"Fam Cancer"},{"key":"9705_CR249","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1086\/321979","volume":"69","author":"JD McKay","year":"2001","unstructured":"McKay JD, Lesueur F, Jonard L et al (2001) Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 69:440-6 https:\/\/doi.org\/10.1086\/321979","journal-title":"Am J Hum Genet"},{"key":"9705_CR250","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1210\/jc.2008-0449","volume":"93","author":"BM Cavaco","year":"2008","unstructured":"Cavaco BM, Batista PF, Sobrinho LG and Leite V (2008) Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. J Clin Endocrinol Metab 93:4426-30 https:\/\/doi.org\/10.1210\/jc.2008-0449","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR251","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10689-017-9984-y","volume":"16","author":"TL Wilson","year":"2017","unstructured":"Wilson TL, Hattangady N, Lerario AM et al (2017) A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers. Fam Cancer 16:561-566 https:\/\/doi.org\/10.1007\/s10689-017-9984-y","journal-title":"Fam Cancer"},{"key":"9705_CR252","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/bjd.17443","volume":"181","author":"M Potrony","year":"2019","unstructured":"Potrony M, Puig-Butille JA, Ribera-Sola M et al (2019) POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families. Br J Dermatol 181:105-113 https:\/\/doi.org\/10.1111\/bjd.17443","journal-title":"Br J Dermatol"},{"key":"9705_CR253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228887","volume":"15","author":"MA Richard","year":"2020","unstructured":"Richard MA, Lupo PJ, Morton LM et al (2020) Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study. PLoS One 15:e0228887 https:\/\/doi.org\/10.1371\/journal.pone.0228887","journal-title":"PLoS One"},{"key":"9705_CR254","doi-asserted-by":"publisher","unstructured":"Srivastava A, Miao B, Skopelitou D et al (2020) A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer. Cancers (Basel) 12 https:\/\/doi.org\/10.3390\/cancers12061441","DOI":"10.3390\/cancers12061441"},{"key":"9705_CR255","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1158\/0008-5472.CAN-08-1071","volume":"69","author":"H He","year":"2009","unstructured":"He H, Nagy R, Liyanarachchi S et al (2009) A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69:625-31 https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1071","journal-title":"Cancer Res"},{"key":"9705_CR256","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1002\/ijc.28543","volume":"134","author":"E Bonora","year":"2014","unstructured":"Bonora E, Rizzato C, Diquigiovanni C et al (2014) The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma. Int J Cancer 134:2098-107 https:\/\/doi.org\/10.1002\/ijc.28543","journal-title":"Int J Cancer"},{"key":"9705_CR257","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/ijc.29557","volume":"137","author":"V Mancikova","year":"2015","unstructured":"Mancikova V, Cruz R, Inglada-Perez L et al (2015) Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations. Int J Cancer 137:1870-8 https:\/\/doi.org\/10.1002\/ijc.29557","journal-title":"Int J Cancer"},{"key":"9705_CR258","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1086\/301610","volume":"61","author":"GR Bignell","year":"1997","unstructured":"Bignell GR, Canzian F, Shayeghi M et al (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123-30 https:\/\/doi.org\/10.1086\/301610","journal-title":"Am J Hum Genet"},{"key":"9705_CR259","doi-asserted-by":"publisher","unstructured":"Zhang T and Xing M (2016) HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer. J Natl Cancer Inst 108:djv415 https:\/\/doi.org\/10.1093\/jnci\/djv415","DOI":"10.1093\/jnci\/djv415"},{"key":"9705_CR260","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1210\/jcem.86.8.7725","volume":"86","author":"S Bevan","year":"2001","unstructured":"Bevan S, Pal T, Greenberg CR et al (2001) A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 86:3701-4 https:\/\/doi.org\/10.1210\/jcem.86.8.7725","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR261","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1086\/302164","volume":"63","author":"F Canzian","year":"1998","unstructured":"Canzian F, Amati P, Harach HR et al (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743-8 https:\/\/doi.org\/10.1086\/302164","journal-title":"Am J Hum Genet"},{"key":"9705_CR262","doi-asserted-by":"publisher","unstructured":"Harach HR, Lesueur F, Amati P et al (1999) Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2. J Pathol 189:387-93\u00a0https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199911)189:3<387::AID-PATH443>3.0.CO;2-S","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<387::AID-PATH443>3.0.CO;2-S"},{"key":"9705_CR263","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1067\/msy.2099.102606","volume":"126","author":"JL Kraimps","year":"1999","unstructured":"Kraimps JL, Canzian F, Jost C et al (1999) Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene. Surgery 126:1188-94 https:\/\/doi.org\/10.1067\/msy.2099.102606","journal-title":"Surgery"},{"key":"9705_CR264","doi-asserted-by":"publisher","first-page":"E973","DOI":"10.1210\/jc.2012-3823","volume":"98","author":"H He","year":"2013","unstructured":"He H, Bronisz A, Liyanarachchi S et al (2013) SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility. J Clin Endocrinol Metab 98:E973-80 https:\/\/doi.org\/10.1210\/jc.2012-3823","journal-title":"J Clin Endocrinol Metab"},{"key":"9705_CR265","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jnci\/djn471","volume":"101","author":"ES Ngan","year":"2009","unstructured":"Ngan ES, Lang BH, Liu T et al (2009) A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1\/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. J Natl Cancer Inst 101:162-75 https:\/\/doi.org\/10.1093\/jnci\/djn471","journal-title":"J Natl Cancer Inst"},{"key":"9705_CR266","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1472-6823-13-48","volume":"13","author":"S Liao","year":"2013","unstructured":"Liao S, Song W, Liu Y et al (2013) Familial multinodular goiter syndrome with papillary thyroid carcinomas: mutational analysis of the associated genes in 5 cases from 1 Chinese family. BMC Endocr Disord 13:48 https:\/\/doi.org\/10.1186\/1472-6823-13-48","journal-title":"BMC Endocr Disord"},{"key":"9705_CR267","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/ijc.31825","volume":"144","author":"F Ye","year":"2019","unstructured":"Ye F, Gao H, Xiao L et al (2019) Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma. Int J Cancer 144:1321-1330 https:\/\/doi.org\/10.1002\/ijc.31825","journal-title":"Int J Cancer"},{"key":"9705_CR268","doi-asserted-by":"publisher","first-page":"10566","DOI":"10.1038\/srep10566","volume":"5","author":"J Tomsic","year":"2015","unstructured":"Tomsic J, He H, Akagi K et al (2015) A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition. Sci Rep 5:10566 https:\/\/doi.org\/10.1038\/srep10566","journal-title":"Sci Rep"},{"key":"9705_CR269","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/sj.bjc.6602547","volume":"92","author":"V Maximo","year":"2005","unstructured":"Maximo V, Botelho T, Capela J et al (2005) Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92:1892-8 https:\/\/doi.org\/10.1038\/sj.bjc.6602547","journal-title":"Br J Cancer"},{"key":"9705_CR270","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/sj.bjc.6603455","volume":"95","author":"E Bonora","year":"2006","unstructured":"Bonora E, Evangelisti C, Bonichon F, Tallini G and Romeo G (2006) Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. Br J Cancer 95:1529-36 https:\/\/doi.org\/10.1038\/sj.bjc.6603455","journal-title":"Br J Cancer"},{"key":"9705_CR271","doi-asserted-by":"publisher","unstructured":"Gasior-Perczak D, Kowalik A, Gruszczynski K et al (2021) Incidence of the CHEK2 Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma. Cancers (Basel) 13 https:\/\/doi.org\/10.3390\/cancers13030470","DOI":"10.3390\/cancers13030470"},{"key":"9705_CR272","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12020-021-02660-x","volume":"73","author":"C Pires","year":"2021","unstructured":"Pires C, Marques IJ, Dias D, Saramago A, Leite V and Cavaco BM (2021) A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer. Endocrine 73:588-597 https:\/\/doi.org\/10.1007\/s12020-021-02660-x","journal-title":"Endocrine"},{"key":"9705_CR273","doi-asserted-by":"publisher","unstructured":"Szeliga A, Pralat A, Witczak W et al (2020) CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report. Int J Environ Res Public Health 17 https:\/\/doi.org\/10.3390\/ijerph17124397","DOI":"10.3390\/ijerph17124397"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-022-09705-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-022-09705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T02:58:28Z","timestamp":1647658708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-022-09705-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":273,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["9705"],"URL":"https:\/\/doi.org\/10.1007\/s12022-022-09705-5","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"22 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All evaluations performed in this analysis do not involve any individual patient\u2019s data but was still performed in accordance with the ethical standards of the institutional review board. The opinions or assertions contained herein are the private views of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"No personally identifiable information is included and thus informed consent is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent Statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}